• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

Cannabis in the News, CBD in the News, CBD Stocks, Hemp, HempFusion, Investment Opportunities, Research, Science

HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York DENVER, Colo., Feb 17, 2021 – HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD...
Why are Psychedelics Vital to the Future of the Mental Health Industry?

Why are Psychedelics Vital to the Future of the Mental Health Industry?

Cannabis in the News, Health, Research, Science

Why are Psychedelics Vital to the Future of the Mental Health Industry? The Covid19 pandemic has certainly been detrimental to the mental well-being of many people in the world this year.  Lockdowns, curfews, working from home, not being allowed to see each other as...
Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis

Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis

Cannabis in the News, Research

Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis Industry’s first clinically validated cannabinoid-based insomnia medication will launch globally PHILADELPHIA, April 7, 2020 /PRNewswire/...
Calyxt Licenses New Technology for Greater Efficiency in Gene-Edited Plants

Calyxt Licenses New Technology for Greater Efficiency in Gene-Edited Plants

Cannabis in the News, Research, Science, Technology/Innovations

Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene-Edited Plants Unique Technology Has Potential to Reduce Gene-Edited Plant Production Timelines & Increase Speed to Market ROSEVILLE, Minn.–(BUSINESS...
Cannabis and Hemp Stocks: How do you Invest Now?

Cannabis and Hemp Stocks: How do you Invest Now?

Cannabis in the News, Cannabis Market, Featured, Hemp, Investment Opportunities, Research

Cannabis and Hemp Stocks: How do you Invest Now? Analysts predict the cannabis and hemp industry will surpass $75 billion dollars in less than a decade. The time to invest in cannabis and hemp is now. In fact, there’s never been a better time in history to start...
Therapix Biosciences Ltd. Announces Shareholder Conference Call

Therapix Biosciences Ltd. Announces Shareholder Conference Call

Cannabis in the News, CBD in the News, Finance, Financial Results, Hemp, Research, Science

Therapix Biosciences Ltd. Announces Shareholder Conference Call  TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...
« Older Entries

Search Cannabis and Hemp Stocks

Cannin’s Stock Picks

Best Hemp Stocks 2021

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Is Supreme Cannabis Stock a Buy?
  • Planet 13: Is This Cannabis Stock Worth the Risk?
  • Best Cannabis Stock for 2021: GrowGeneration
  • 2 Common Mistakes to Avoid When Investing in Cannabis Stocks
  • How Do I Invest in Cannabis Stocks?
  • HempFusion: Is this Hemp Stock Still a Buy?
  • Should You Buy Cronos Stock After its Q4 Earnings?
HempFusion TSX CBD Hemp Stocks

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

Cannin Monthly Subscription with Trading Alerts

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 30-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Cannin’s Track Record

Hemp Stocks CBD Stocks Free Stock Tips

The Best Cannabis Stocks for 2021

  • The Cannin Report 2020 $99.00 $49.00
  • FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick $9.99 $0.00
  • Cannin Report Q1 2020 - Aphria $9.99 $4.99
  • Cannin Report Q1 2020 - Cronos Group $9.99 $4.99
  • Cannin Report Q1 2020 - iAnthus $9.99 $4.99

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

HempFusion TSX CBD Hemp Stocks

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
Terms:
1 month for free then $49 / Month
First Name Required
Last Name Required
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above